Haotian Pharmatech Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
500
- Latest Deal Type
-
M&A
- Investors
-
11
Haotian Pharmatech General Information
Description
Provider of drug research and development services intended to serve medical industry. The company specializes in the R&D, production and sales of specialty active pharmaceutical ingredient (API) and intermediates including OEB-5-level high-activity pharmaceutical material, photoreaction, enzyme fermentation and catalysis, etc., and provides contract research and development and contract manufacturing of new drugs (CDMO/CMO), enabling clients with various types of raw materials and customized production of new drugs.
Contact Information
Website
haotianpharmatech.com(Operating Subsidiary)
Corporate Office
- Innovation Building, Innovation Park, High-tech Zone
- No. 18, Yannan Road, Chengguan District
- Lanzhou, Gansu 730000
- China
Corporate Office
- Innovation Building, Innovation Park, High-tech Zone
- No. 18, Yannan Road, Chengguan District
- Lanzhou, Gansu 730000
- China
Haotian Pharmatech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 28-Aug-2024 | Completed | Profitable | |||
| 9. IPO | 21-Dec-2023 | Cancelled | Profitable | |||
| 8. Secondary Transaction - Private | 21-Nov-2022 | Completed | Profitable | |||
| 7. Later Stage VC | 05-Jul-2022 | Completed | Profitable | |||
| 6. Secondary Transaction - Private | 14-Feb-2022 | Completed | Profitable | |||
| 5. Later Stage VC | 10-Aug-2020 | Completed | Profitable | |||
| 4. Later Stage VC | 07-Apr-2020 | Completed | Profitable | |||
| 3. Later Stage VC | 07-May-2019 | Completed | Profitable | |||
| 2. Later Stage VC | 01-Jan-2017 | $8.12M | $8.36M | Completed | Generating Revenue | |
| 1. Later Stage VC | 01-Jan-2016 | $247K | $247K | Completed | Generating Revenue |
Haotian Pharmatech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 1,351,400 | $5.52 | $5.52 | 1x | $5.52 | 9.72% | ||
| Ordinary | 1,351,351 | $5.52 | $5.52 | 1x | $5.52 | 9.72% |
Haotian Pharmatech Signals
Haotian Pharmatech Investments (4)
Haotian Pharmatech’s most recent deal was a Early Stage VC with BDSyn Bio. The deal was made on 30-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BDSyn Bio | 30-Sep-2024 | Early Stage VC | Biotechnology | ||
| Gansu Pharmaceutical Group Science and Technology Research Institute | 10-Jul-2020 | Joint Venture | Other Pharmaceuticals and Biotechnology | ||
| Guizhou Haotian Optoelectronics Technology | 13-Dec-2019 | Secondary Transaction - Private | Other Commercial Products | ||
| TalkingData | 26-Nov-2013 | Early Stage VC | Business/Productivity Software |
Haotian Pharmatech FAQs
-
When was Haotian Pharmatech founded?
Haotian Pharmatech was founded in 2009.
-
Where is Haotian Pharmatech headquartered?
Haotian Pharmatech is headquartered in Lanzhou, China.
-
What is the size of Haotian Pharmatech?
Haotian Pharmatech has 500 total employees.
-
What industry is Haotian Pharmatech in?
Haotian Pharmatech’s primary industry is Pharmaceuticals.
-
Is Haotian Pharmatech a private or public company?
Haotian Pharmatech is a Private company.
-
What is Haotian Pharmatech’s current revenue?
The current revenue for Haotian Pharmatech is .
-
How much funding has Haotian Pharmatech raised over time?
Haotian Pharmatech has raised $49.6M.
-
When was Haotian Pharmatech acquired?
Haotian Pharmatech was acquired on 28-Aug-2024.
-
Who acquired Haotian Pharmatech?
Haotian Pharmatech was acquired by Gansu Mogao Industrial Development Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process